Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies
- 2 March 2007
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 136 (6) , 829-832
Abstract
Summary: Epigenetic silencing of tumour suppressor genes (TSG) inactivates TSG functions. Previously, we identified PCDH10 as a methylated TSG in carcinomas. Here, we detected its frequent silencing and methylation in lymphoma cell lines including 100% Burkitt, 100% diffuse large B cell, 86% Hodgkin, 100% nasal natural killer/T‐cell lymphoma and 1/3 of leukaemia cell lines, and in primary tumours but not in normal peripheral blood mononuclear cells or lymph nodes. PCDH10 silencing could be reversed by demethylation with 5‐aza‐2′‐deoxycytidine. Methylation was further detected in 14% of Hodgkin lymphoma sera. Thus, PCDH10 methylation is frequently involved in lymphomagenesis and could serve as a tumour‐specific biomarker.Keywords
This publication has 12 references indexed in Scilit:
- Frequent Silencing of the Candidate Tumor Suppressor PCDH20 by Epigenetic Mechanism in Non–Small-Cell Lung CancersCancer Research, 2006
- Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1Nature Genetics, 2005
- Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylationOncogene, 2005
- The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple TumorsClinical Cancer Research, 2005
- Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in AstrocytomasNeoplasia, 2005
- Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemiaNature Genetics, 2005
- Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal CancerCancer Research, 2004
- Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphomaOncogene, 2004
- Epigenetic targets in hematopoietic malignanciesOncogene, 2003
- Methylation Status of the Epstein-Barr Virus Major Latent Promoter C in Iatrogenic B Cell Lymphoproliferative DiseaseThe American Journal of Pathology, 1999